                         SEQUENCE LISTING

<110>  Dana-Farber Cancer Institute, Inc.
 
<120>  METHODS OF IDENTIFYING COMPOUNDS THAT INTERFERE WITH ERG-DRIVEN 
       MISGUIDANCE OF BAF COMPLEXES IN TMPRSS2-ERG DRIVEN PROSTATE 
       CANCERS

<130>  586149:DFC-003PC

<140>  PCT /US 16/062911
<141>  2016-11-18

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  41
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  poiyomavirus enhancer (Py) probe IRD800

<400>  1
gatctttaag caggaagtga ctaactgacc gcaggtggat c                           41


